U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.841C>T (p.Pro281Ser) AND Familial cancer of breast

Germline classification:
Conflicting interpretations of pathogenicity (5 submissions)
Last evaluated:
Mar 5, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000226615.19

Allele description [Variation Report for NM_000465.4(BARD1):c.841C>T (p.Pro281Ser)]

NM_000465.4(BARD1):c.841C>T (p.Pro281Ser)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.841C>T (p.Pro281Ser)
Other names:
p.P281S:CCA>TCA
HGVS:
  • NC_000002.12:g.214781033G>A
  • NG_012047.3:g.33679C>T
  • NM_000465.4:c.841C>TMANE SELECT
  • NM_001282543.2:c.784C>T
  • NM_001282545.2:c.215+16028C>T
  • NM_001282548.2:c.158+28379C>T
  • NM_001282549.2:c.364+11264C>T
  • NP_000456.2:p.Pro281Ser
  • NP_001269472.1:p.Pro262Ser
  • LRG_297t1:c.841C>T
  • LRG_297:g.33679C>T
  • LRG_297p1:p.Pro281Ser
  • NC_000002.11:g.215645757G>A
  • NG_012047.2:g.33672C>T
  • NM_000465.2:c.841C>T
  • NM_000465.3:c.841C>T
  • NR_104212.2:n.806C>T
  • NR_104215.2:n.749C>T
Protein change:
P262S
Links:
dbSNP: rs200059956
NCBI 1000 Genomes Browser:
rs200059956
Molecular consequence:
  • NM_001282545.2:c.215+16028C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+28379C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.364+11264C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000465.4:c.841C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.784C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.806C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.749C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000284981Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 16, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV000786120Counsyl
criteria provided, single submitter

(Counsyl Autosomal Dominant Disease Classification criteria (2015))
Uncertain significance
(Feb 28, 2018)
unknownclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Counsyl_Autosomal_Dominant_Disease_Classification_criteria_(2015)_v1.pdf,

Citation Link,

SCV000837975Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2017)
Uncertain significance
(Jul 2, 2018)
unknownclinical testing

Citation Link,

SCV004019265Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Likely benign
(Feb 24, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV004214995Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 5, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.

Landovitz RJ, Tran TT, Cohn SE, Ofotokun I, Godfrey C, Kuritzkes DR, Lennox JL, Currier JS, Ribaudo HJ.

AIDS Behav. 2016 Dec;20(12):2983-2995.

PubMed [citation]
PMID:
26979419
PMCID:
PMC5026544

Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.

Sandoval RL, Leite ACR, Barbalho DM, Assad DX, Barroso R, Polidorio N, Dos Anjos CH, de Miranda AD, Ferreira ACSM, Fernandes GDS, Achatz MI.

PLoS One. 2021;16(2):e0247363. doi: 10.1371/journal.pone.0247363.

PubMed [citation]
PMID:
33606809
PMCID:
PMC7895369
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000284981.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 281 of the BARD1 protein (p.Pro281Ser). This variant is present in population databases (rs200059956, gnomAD 0.004%). This missense change has been observed in individual(s) with breast cancer and colon cancer (PMID: 25980754, 26979419, 27978560, 33606809, 34250417). ClinVar contains an entry for this variant (Variation ID: 127749). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Counsyl, SCV000786120.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV000837975.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV004019265.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004214995.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024